$CSLM
CSLM ACQUISITION CORP.

2022 Q4 Form 10-K Financial Statement

#000119312523087999 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $462.0K
YoY Change
Gross Profit -$462.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $209.2K $1.028M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $216.0K $1.063M
YoY Change 11835.91% 2063.03%
Operating Profit -$1.063M
YoY Change
Interest Expense $1.754M $3.120M
YoY Change
% of Operating Profit
Other Income/Expense, Net $10.00 $3.120M
YoY Change
Pretax Income $1.538M $2.057M
YoY Change -85074.59% -4285.68%
Income Tax
% Of Pretax Income
Net Earnings $1.538M $2.057M
YoY Change -85074.59% -4285.67%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.09
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $195.0M $195.0M
YoY Change 974961700.0% 974961700.0%
Cash & Equivalents $224.5K
Short-Term Investments $194.8M $194.8M
Other Short-Term Assets $494.8K $494.8K
YoY Change
Inventory
Prepaid Expenses $494.8K
Receivables
Other Receivables $28.46K
Total Short-Term Assets $195.5M $195.5M
YoY Change 977578225.0% 977578250.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $195.5M $195.5M
Total Long-Term Assets $0.00 $0.00
Total Assets $195.5M $195.5M
YoY Change 23105.51% 23105.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.185K $8.190K
YoY Change
Accrued Expenses $308.0K $587.6K
YoY Change 526.28% -20.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.237M $7.237M
YoY Change 735.02% 735.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.237M $7.237M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $7.237M $7.237M
YoY Change 735.02% 735.03%
SHAREHOLDERS EQUITY
Retained Earnings -$6.490M
YoY Change 13102.94%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.489M $188.3M
YoY Change
Total Liabilities & Shareholders Equity $195.5M $195.5M
YoY Change 23105.51% 23105.51%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.538M $2.057M
YoY Change -85074.59% -4285.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $355.1K -$1.294M
YoY Change 1775400.0% -6472395.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$191.6M
YoY Change
Cash From Investing Activities $0.00 -$191.6M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $189.8M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -410.9K 193.2M
YoY Change
NET CHANGE
Cash From Operating Activities 355.1K -1.294M
Cash From Investing Activities 0.000 -191.6M
Cash From Financing Activities -410.9K 193.2M
Net Change In Cash -55.85K 224.5K
YoY Change -279350.0% 1122170.0%
FREE CASH FLOW
Cash From Operating Activities $355.1K -$1.294M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001875493
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41219
CY2022 dei Entity Registrant Name
EntityRegistrantName
CONSILIUM ACQUISITION CORP I, LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1602789
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2400 E. Commercial Boulevard
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 900
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Ft. Lauderdale
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33308
CY2022 dei City Area Code
CityAreaCode
954
CY2022 dei Local Phone Number
LocalPhoneNumber
315-9380
CY2022 dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
CSLM
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
185575500
CY2022 dei Auditor Firm
AuditorFirmId
243
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224474
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
494844
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
28462
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
194767885
CY2022Q4 us-gaap Assets Current
AssetsCurrent
195515665
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
842520
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
842520
CY2022Q4 us-gaap Assets
Assets
195515665
CY2021Q4 us-gaap Assets
Assets
842540
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8185
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
307966
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49174
CY2022Q4 cslm Accrued Offering Costs Current
AccruedOfferingCostsCurrent
279678
CY2021Q4 cslm Accrued Offering Costs Current
AccruedOfferingCostsCurrent
690626
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
126894
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
6641250
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7237079
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
866694
CY2022Q4 us-gaap Liabilities
Liabilities
7237079
CY2021Q4 us-gaap Liabilities
Liabilities
866964
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
194767885
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24526
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6489773
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49154
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6489299
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-24154
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195515665
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
842540
CY2022 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
462043
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
0
CY2022 cslm Dues And Subscriptions
DuesAndSubscriptions
148413
cslm Dues And Subscriptions
DuesAndSubscriptions
0
CY2022 us-gaap Professional Fees
ProfessionalFees
417399
us-gaap Professional Fees
ProfessionalFees
0
CY2022 us-gaap Sponsor Fees
SponsorFees
24462
us-gaap Sponsor Fees
SponsorFees
0
CY2022 cslm Formation Costs
FormationCosts
10813
cslm Formation Costs
FormationCosts
49154
CY2022 us-gaap Operating Expenses
OperatingExpenses
1063130
us-gaap Operating Expenses
OperatingExpenses
49154
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1063130
us-gaap Operating Income Loss
OperatingIncomeLoss
-49154
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
3120385
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3120385
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2057255
us-gaap Net Income Loss
NetIncomeLoss
-49154
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-24154
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16418477
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7942500
CY2022 cslm Remeasurement Of Class A Ordinary Shares Subject To Redemption To Redemption Value
RemeasurementOfClassAOrdinarySharesSubjectToRedemptionToRedemptionValue
-32883377
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2057255
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6489299
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
us-gaap Net Income Loss
NetIncomeLoss
-49154
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-24154
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2057255
us-gaap Net Income Loss
NetIncomeLoss
-49154
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3120385
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
494844
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3462
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8185
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
258792
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
49174
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1294459
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20
CY2022 cslm Purchase Of Treasury Securities From Proceeds Of Redemption On Treasury Securities
PurchaseOfTreasurySecuritiesFromProceedsOfRedemptionOnTreasurySecurities
-768721500
CY2022 cslm Payment For Purchase Of Treasury Securities
PaymentForPurchaseOfTreasurySecurities
-577074000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191647500
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
189750000
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
7942500
CY2022 cslm Payment Of Underwriting Fee
PaymentOfUnderwritingFee
3795000
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
181313
CY2022 cslm Due From Related Party Classified As Financing Activities
DueFromRelatedPartyClassifiedAsFinancingActivities
-25000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
524774
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
193166413
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
224454
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224474
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20
CY2022 cslm Remeasurement Of Ordinary Shares Subject To Possible Redemption
RemeasurementOfOrdinarySharesSubjectToPossibleRedemption
32883377
CY2022 cslm Deferred Underwriter Fee Payable
DeferredUnderwriterFeePayable
6641250
CY2022 cslm Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
410948
cslm Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
690625
cslm Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Classb Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassbOrdinaryShares
25000
cslm Deferred Offering Costs Paid By Sponsor
DeferredOfferingCostsPaidBySponsor
126894
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
one right to acquire one-tenth of an Ordinary Share, and one-half of one redeemable warrant
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
189750000
CY2022Q4 cslm Class Of Warrants Or Rights Redemption Price Per Unit
ClassOfWarrantsOrRightsRedemptionPricePerUnit
10
CY2022 cslm Companys Operating Account
CompanysOperatingAccount
2250000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
191647500
CY2022Q4 cslm Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224474
CY2022Q4 cslm Net Working Capital
NetWorkingCapital
151951
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div>
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
191647500
CY2022 cslm Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022Q4 cslm Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2057255
CY2022 cslm Remeasurement Of Class A Ordinary Shares Subject To Redemption To Redemption Value
RemeasurementOfClassAOrdinarySharesSubjectToRedemptionToRedemptionValue
-32883377
CY2022 cslm Net Income Loss Including Remeasurement Of Temporary Equity To Redemption Value
NetIncomeLossIncludingRemeasurementOfTemporaryEquityToRedemptionValue
-30826122
us-gaap Net Income Loss
NetIncomeLoss
-49154
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4743750
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4743750
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
18975000
CY2022 cslm Fair Value Allocated To Public Warrants
FairValueAllocatedToPublicWarrants
-4524000
CY2022 cslm Fair Value Allocated To Rights
FairValueAllocatedToRights
-12948540
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
28462
CY2022 cslm Due From Related Party Classified As Financing Activities
DueFromRelatedPartyClassifiedAsFinancingActivities
-25000
CY2022 cslm Payment On Behalf Of Sponsor
PaymentOnBehalfOfSponsor
3462
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed Federally insured limits. Exposure to cash and cash equivalents credit risk is reduced by placing such deposits with major financial institutions and monitoring their credit ratings. At December 31, 2022 and 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div>
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
191647500
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2022Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
20
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
194767885
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0

Files In Submission

Name View Source Status
cslm-20221231_def.xml Edgar Link unprocessable
d455605d10k_htm.xml Edgar Link completed
cslm-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001193125-23-087999-index-headers.html Edgar Link pending
0001193125-23-087999-index.html Edgar Link pending
0001193125-23-087999.txt Edgar Link pending
0001193125-23-087999-xbrl.zip Edgar Link pending
cslm-20221231.xsd Edgar Link pending
cslm-20221231_lab.xml Edgar Link unprocessable
cslm-20221231_pre.xml Edgar Link unprocessable
d455605d10k.htm Edgar Link pending
d455605dex311.htm Edgar Link pending
d455605dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending